Legacy Financial Strategies, LLC Exact Sciences Corp Transaction History

Legacy Financial Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $166,944 - $229,492	-1,850 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$99.61 - $142.12 $184,278 - $262,922	1,850 New	1,850 $245,000
Q3 2019 Nov 01, 2019	SELL	$90.37 - $122.49 $167,184 - $226,606	-1,850 Closed	0 $0
Q2 2019 Jul 15, 2019	BUY	$89.51 - $118.04 $165,593 - $218,374	1,850 New	1,850 $215,000

670

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Legacy Financial Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Strategies, LLC with notifications on news.